Novartis AGNVSNYSE
Loading
Year-over-year operating cash flow growth rate
Percentile
P0
Near historical low
vs 5Y Ago
-2.4x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -65.70% |
| Q3 2025 | -1.40% |
| Q2 2025 | 82.83% |
| Q1 2025 | -13.07% |
| Q4 2024 | -33.30% |
| Q3 2024 | 28.94% |
| Q2 2024 | 115.23% |
| Q1 2024 | -11.07% |
| Q4 2023 | -52.64% |
| Q3 2023 | 50.39% |
| Q2 2023 | 20.93% |
| Q1 2023 | -28.07% |
| Q4 2022 | -12.92% |
| Q3 2022 | 25.73% |
| Q2 2022 | 127.71% |
| Q1 2022 | -57.54% |
| Q4 2021 | -21.14% |
| Q3 2021 | 19.19% |
| Q2 2021 | 93.99% |
| Q1 2021 | -46.82% |
| Q4 2020 | 26.90% |
| Q3 2020 | -20.32% |
| Q2 2020 | 56.69% |
| Q1 2020 | -28.59% |
| Q4 2019 | -22.40% |
| Q3 2019 | 46.64% |
| Q2 2019 | 28.98% |
| Q1 2019 | -35.95% |
| Q4 2018 | -7.01% |
| Q3 2018 | 2.74% |
| Q2 2018 | 56.80% |
| Q1 2018 | -26.23% |
| Q4 2017 | -4.96% |
| Q3 2017 | 0.11% |
| Q2 2017 | 75.16% |
| Q1 2017 | -43.05% |
| Q4 2016 | 11.14% |
| Q3 2016 | 3.86% |
| Q2 2016 | 101.75% |
| Q1 2016 | -62.91% |